Jane E. Henney

Q: What Schools Are Affiliated With Jane E. Henney

Jane E. Henney is affiliated with the following schools: University of Cincinnati, University of New Mexico, Manchester University

Jane E. Henney's AcademicInfluence.com Rankings

Jane E. Henney

Philosophy

#10447

World Rank

#14319

Historical Rank

#1927

USA Rank

Ontology

#161

World Rank

#187

Historical Rank

#17

USA Rank

Logic

#8728

World Rank

#10953

Historical Rank

#1470

USA Rank

philosophy Degrees

Download Badge

Philosophy

Why Is Jane E. Henney Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Jane Ellen Henney is an American physician who was the first woman to serve as commissioner of the U.S. Food and Drug Administration. Appointed by President Bill Clinton, she served at the FDA from 1999 to 2001.

(See a Problem?)

Jane E. Henney's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Strategies to Reduce Sodium Intake in the United States (2010) (475)
Current results of the screening program at the Division of Cancer Treatment, National Cancer Institute. (1981) (218)
Vital Directions for Health and Health Care: Priorities From a National Academy of Medicine Initiative (2017) (148)
Withdrawal of Troglitazone and Cisapride (2000) (92)
Infant Pneumococcal Vaccine (2000) (74)
Miconazole therapy for treatment of fungal infections in cancer patients (1979) (44)
Risk of Drug Interactions With St John's Wort (2000) (43)
Cyberpharmacies and the role of the US Food And Drug Administration (2001) (39)
Internet Purchase of Prescription Drugs: Buyer Beware (1999) (36)
Review of Generic Bioequivalence Studies (1999) (36)
A computer data base for information on cancer treatment. (1987) (35)
Committee on Strategies to Reduce Sodium Intake (2010) (33)
Taste and Flavor Roles of Sodium in Foods: A Unique Challenge to Reducing Sodium Intake (2010) (27)
Treatment of primary breast cancer. Summary of the National Institutes of Health Consensus Development Conference. (1980) (27)
Parkinson Treatment Approval (1999) (26)
Celecoxib Indicated for FAP (2000) (24)
Challenges in Regulating Direct-to-Consumer Advertising (2000) (23)
Role of antitumor antibiotics in current oncologic practice. (1978) (23)
New Inhaled Corticosteroid (2000) (22)
Preservation and Physical Property Roles of Sodium in Foods (2010) (21)
Shock Wave for Heel Pain (2000) (21)
First Drug for Penicillin-Resistant Community-Acquired Pneumonia (2000) (16)
Revised Labeling for Cisapride (2000) (16)
New Drug for Refractory Cutaneous T-Cell Lymphoma (2000) (14)
Complications Related to Vascular Hemostasis Devices (1999) (13)
New Indication for Fluoxetine (2000) (12)
Microwave Therapy Warning (2000) (12)
Time to Reevaluate U.S. Mifepristone Restrictions. (2019) (12)
Nationwide Recall of SangCya Oral Solution (2000) (11)
The evolution of primary multimodality treatment in resectable breast cancer (1980) (11)
Sodium-Intake Reduction and the Food Industry. (2019) (10)
Multimodal treatment of primary breast carcinoma: analysis of accomplishments and problem areas. (1981) (9)
Safeguarding Patient Welfare: Who's In Charge? (2006) (9)
Endotoxin-like Reactions to Gentamicin Sulfate (1999) (9)
Seven Former FDA Commissioners: The FDA Should Be An Independent Federal Agency. (2019) (8)
Preventive Use for Ramipril (2000) (8)
Thrombophlebitic Potential of Intravenous Cytotoxic Agents (1977) (7)
New Therapy for Macular Degeneration (2000) (7)
Sertraline Approved for Posttraumatic Stress Disorder (2000) (7)
Drug Product Problem Reports (2000) (6)
FDA Oncology Tools on Internet (2000) (6)
Recommended Strategies to Reduce Sodium Intake and to Monitor Their Effectiveness (2010) (6)
Continuing Shortage of IGIV (1999) (5)
National Salt Reduction Initiative Coordinated by the New York City Health Department (2010) (5)
Implant for Chronic Nausea (2000) (5)
Quick Test for Pneumonia (1999) (5)
Revised Labeling for Zanamivir (2000) (5)
New Type 2 Diabetes Drugs (1999) (5)
New Drug for Sleeplessness (1999) (5)
New First-Line Therapy for Colorectal Cancer (2000) (4)
The Food Environment: Key to Formulating Strategies for Change in Sodium Intake (2010) (4)
Sodium Intake Reduction: An Important But Elusive Public Health Goal (2010) (4)
From the food and drug administration. (2001) (4)
Joint Meeting of Advisory Committees (2000) (4)
Approval of TMJ Prosthesis (1999) (4)
FDA's Proposed Strategy on Reuse of Single-Use Devices (2000) (3)
Infections From Endoscopes (1999) (3)
Alternative Supply of Penicillin G (2000) (3)
Breakout II: Reimbursement concerns (1990) (2)
Web Site for Clinical Investigators (2000) (2)
First Antibacterial for VREF (1999) (2)
Clarification on Buprenorphine (2000) (2)
Elevated Cholesterol Treatment (2000) (2)
The role of antitumor antibiotics in current oncologic practice (2004) (2)
From the Food and Drug Administration. (2000) (2)
Combatting medical fraud. (1993) (2)
New Treatment for Leukemia (2000) (2)
Clinical trials with cis-diamminedichloroplatinum (II) (DDP) (1978) (2)
Setting priorities for effectiveness research (1991) (1)
General progress in clinical chemotherapy of advanced disease. (1980) (1)
Advances in the multimodal primary management of cancer. (1980) (1)
Toxicity Testing: The FDA Perspective (2000) (1)
MSJAMA: challenges in regulating direct-to-consumer advertising. (2000) (1)
Remarks of the Commissioner of Food and Drugs. (1999) (1)
Bacterial Contamination Alert (2000) (1)
Important Warning About Alosetron Hydrochloride (2000) (1)
New Combination Drug for HIV (2001) (1)
New System for Monitoring Intrapartum Fetal Oxygen Saturation (2000) (1)
New Drug for Stroke (2000) (1)
First Drug Device to Treat Actinic Keratoses (2000) (1)
Warning on Dietary Supplements (1999) (0)
The Regulatory Framework: A Powerful and Adaptable Tool for Sodium Intake Reduction (2010) (0)
Committee’s Considerations and Basis for Recommendations (2010) (0)
Federal Rulemaking Process (2010) (0)
From the Food and Drug Administration. (2000) (0)
Public Information-Gathering Workshop Agenda (2010) (0)
Direct sale of sildenafil (Viagra) to consumers over the Internet. (2000) (0)
From the Food and Drug Administration. (1999) (0)
TABLE 5-6, Mean 1-Day Sodium Intake Density (mg/1,000 kcal) from Foodsa by Age and Gender (2010) (0)
Surgical Sealant for Lung Cancer (2000) (0)
Background on the National Health and Nutrition Examination Surveys and Data Analysis Methods (2010) (0)
Guidance for Adverse Reactions Labeling (2000) (0)
From the Food and Drug Administration. (1999) (0)
Devices for In-Stent Restenosis (2001) (0)
Prognostic factors and management of axillary node negative breast cancer. (1991) (0)
From the Food and Drug Administration. (2000) (0)
Approach to Linking Universal Product Code (UPC) Sales Data to the Nutrition Facts Panel (2010) (0)
From the Food and Drug Administration. (2000) (0)
Sodium Intake Tables (2010) (0)
Remarks of the Commissioner of Food and Drugs. (2000) (0)
From the Food and Drug Administration. (2000) (0)
Acronyms, Abbreviations, and Glossary (2011) (0)
From the Food and Drug Administration. (1999) (0)
From the Food and Drug Administration. (2000) (0)
Are bioengineered foods safe?. Interview by Larry Thompson. (2000) (0)
TABLE 4-2, Hurdles That Could Be Added to Counteract Microbial Activity in Sodium-Reduced Foods (2010) (0)
Nutrition Facts Panel (2010) (0)
From the Food and Drug Administration. (2000) (0)
Nominations for Advisory Panels (2001) (0)
39 Cis-diamminedichloroplatinum II. Clinical applications (1978) (0)
International Efforts to Reduce Sodium Consumption (2010) (0)
TREATMENT OF EARLY BREAST CANCER, AND RECONSTRUCTION (1978) (0)
Sodium Intake Estimates for 2003–2006 and Description of Dietary Sources (2010) (0)
New Hearing Implant Approved (2000) (0)
From the Food and Drug Administration. (2000) (0)
State and Local Sodium Labeling Initiatives (2010) (0)
Mid-America Coalition on Health Care: Managing Medical Risk: Current and Future Challenges: Remarks by Jane E. Henney: (310592004-001) (2000) (0)
Steering committee (2004) (0)
Injunction Affecting Abbott's in Vitro Test Devices (2000) (0)
From the Food and Drug Administration. (2000) (0)
Salt Substitutes and Enhancers (2010) (0)
Government Initiatives and Past Recommendations of the National Academies, the World Health Organization, and Other Health Professional Organizations (2010) (0)
Introductory remarks. (1987) (0)
New Drug for HIV Infection (2000) (0)
From the Food and Drug Administration. (2000) (0)
From the Food and Drug Administration. (1999) (0)
Future prospectives in the treatment of breast cancer. (1978) (0)
Elwood Jensen and Sohaib Khan interviewed by Jane Henney and Peter Stambrook, August 13, 2007 (2007) (0)

This paper list is powered by the following services:

Other Resources About Jane E. Henney

en.wikipedia.org

What Schools Are Affiliated With Jane E. Henney?

Jane E. Henney is affiliated with the following schools:

Jane E. Henney's Academic­Influence.com Rankings

Why Is Jane E. Henney Influential?

Jane E. Henney's Published Works

Published Works

Other Resources About Jane E. Henney

What Schools Are Affiliated With Jane E. Henney?

Image Attributions

Jane E. Henney's AcademicInfluence.com Rankings